Background/Aims: Ischemic heart disease is a leading cause of death in cardiovascular diseases, and microRNAs (miRs) have been reported to be potential therapeutic targets in heart disease. Herein, this study aims to investigate the effects of microRNA (miR)-374 on myocardial ischemia-reperfusion (I/R) injury in rat models pretreated with sevoflurane by targeting SP1 through the PI3K/Akt pathway. Methods: SD rats were grouped into sham, I/R and sevoflurane + I/R (sevoflurane preconditioning and I/R) groups. The biochemical indicators, pathological changes, positive expression of SP1 protein, and apoptosis rates were measured using biochemical detection, Evans blue-TTC staining, immunohistochemistry and TUNEL staining. RT-qPCR and Western blotting were used to investigate the expression of miR-374 mRNA and the protein expression of SP1, PI3K, HO-1, p53, iNOS, c-fos, Akt/p-Akt, and GSK-3β/p-GSK-3β. Cardiomyocytes were treated with miR-374 mimics, miR-374 inhibitors, or siRNA-SP1. Cardiomyocyte proliferation and cycle distribution and apoptosis were studied by MTT and flow cytometry. Results: Compared with the I/R group, in the sevoflurane + I/R group, serum SOD and IL-10 increased, while MDA, LDH, CK, TNF-α, IL-6 and IL-10 decreased, as did the percentage of infarct area, the positive rate of SP1 and the apoptosis index. The expression of SP1, p53, iNOS and c-fos decreased, and the miR-374 expression of PI3K, HO-1, Akt/p-Akt, GSK-3β/p-GSK-3β increased. With the upregulation of miR-374 and the downregulation of SP1, the expression of SP1, p53, iNOS and c-fos decreased, as did the proportion of cells in G1 phase and the apoptosis rate; the expression of PI3K, HO-1, Akt/pAkt, GSK-3β/p-GSK-3β increased. The results in the miR-374 inhibitor group contrasted with the above results. Conclusion: The results indicated that miR-374 could alleviate myocardial I/R damage in rat models pretreated with sevoflurane by targeting SP1 by activating the PI3K/ Akt pathway.
Introduction
Ischemic heart disease is the main cause of death in cardiovascular diseases, and blood supply restoration, such as reperfusion therapy, which is believed to be the most effective treatment for myocardial ischemia, although it may exacerbate or even cause irreversible damage [1] . Occurring at the time of reperfusion of ischemic myocardium with oxygen and substrate-rich blood, reperfusion could sometimes paradoxically deteriorate heart function [2] . Anesthetics such as sevoflurane and isoflurane are reported to be valid therapeutic drugs for I/R injury [3] . Except for its fast induction, rapid recovery and low possibility of "coronary arterial steal", sevoflurane has proved to protect the heart against myocardial I/R injury, enhancing recovery of cardiac function, reducing myocardial enzyme release and lowering infarct size when utilized as pretreatment or posttreatment agents [4] . However, the possible mechanism that is responsible for sevoflurane mediating cardioprotection is still unknown [5] .
Endogenous 18-22-nucleotide microRNAs (miRs), such as miR-374a and miR-374b, are considered to play significant roles in cell differentiation, proliferation and apoptosis [6] [7] [8] . According to a recent study, miR-22 with its target CBP could suppress apoptosis of cardiomyocytes, providing a new, valid therapeutic target for preventing myocardial I/R injury [9] . Furthermore, another study showed that up-regulation of miR-15a and miR-15b were in response to cardiac I/R injury, indicating that the down-regulation of miR-15a or miR15b might be a practical way to inhibit myocardial apoptosis caused by myocardial I/R injury [10] . Lately, it was shown that miRs could be potential therapeutic targets for alleviating I/R injury through altering key signaling elements [11] . It has been demonstrated that by suppressing CCND1, miR-374a could inactivate the PI3K/AKT axis, inducing the inhibition of colon cancer progression [12] . As an important part of the protective mechanism of ischemic preconditioning, the phosphoinositide 3-kinase (PI3K)/Akt pathway plays a major role in controlling cell growth, survival, proliferation and migration, with an improving function in I/R through activating Akt [13] . As a series of heterodimeric enzymes, PI3Ks are composed of a p110 catalytic subunit and a p85 regulatory that could induce the formation of 3-polyphosphoinositides, thus mediating cell division, migration and survival [14] . Additionally, LINC00152 was reported to participate in the PI3K/Akt signaling pathway, with the transcription factor SP1 inducing its overexpression [15] . However, the role of miR-374 in myocardial I/R was not explored. Therefore, this study estimated the effects of miR-374 in rat models of myocardial I/R pretreated with sevoflurane by targeting the transcription factor SP1 through activating the PI3K/Akt pathway.
Materials and Methods

Experimental animals
A total of 60 male Sprague-Dawley (SD) rats, weighing 180 to 250 g and aged from 6 to 8 weeks, were provided by the North China University of Science and Technology Affiliated Hospital, bred in cages individually with humidity of 55% at 25°C for two weeks with free diet and water intake in dark and under light (12 h/12 h); all mice were fed adaptively for 2 weeks before experiments. This experiment procedure and animal operation protocols were approved by the animal ethics committee.
Model establishment, identification and grouping
Forty-five SD rats were randomly selected and then assigned into the sham group, I/R group and sevoflurane + I/R group (2.5% sevoflurane [Shanghai Yongye Biotechnology Co., Ltd., Shanghai, China] preconditioning and I/R). The rats in each group were anesthetized by intraperitoneal injection of 1% pentobarbital sodium at 45 mg/kg (Sigma-Aldrich Chemical Company, St. Louis, MO, USA) and given ventilator-assisted ventilation through endotracheal intubation (RSP1002, Pushengda Teksystems Ltd., Beijing, China). Then, left thoracotomy was conducted. The model of myocardial I/R injury was established by ligating the left anterior descending branch (LAD) at 3 mm from the inferior border of the left atrial appendage by using 6/0 suture, and then releasing the suture line and reperfusion for 2 h [16] . Rats in the sham group underwent thread ligation only, and rats in the sevoflurane + I/R group received 2.5% sevoflurane for 30 min before ischemia. Fifteen min later, the I/R model was established as described above. Rats that died in the surgery were immediately replaced. When the anterior wall in the distal end of the ligation site was observed to have cyanosis or pale with naked eyes, ECG (SP2006, Beijing Senxi Technology Co., Ltd., Beijing, China) showed that the S-T segment was elevated and the T wave was ascended, which meant myocardial ischemia. The decrease of the S-T segment, recovery of the R wave in ECG or the ischemic region turning red were the indications of successful reperfusion. Intraoperative temperature of the rats was maintained at 36~38°C.
Cardiac function test
The left ventricular end diastolic pressure (LVEDP), left ventricular developed pressure (LVDP), left ventricular pressure rising maximum rate (+dp/dt max ), left ventricular pressure dropping maximum rate (-dp/dt max ), heart rate (HR) and coronary flow (CF) were observed and recorded at the time of 30, 60, 90 and 120 min after reperfusion using the 16-channel physiological recorder biological signal analysis system (MP100, BIOPAC Systems, Inc., Santa Barbara, CA, USA).
Biochemical testing
Two hours after reperfusion, 3 mL thigh arterial blood was collected. After centrifugation at 3500 r/ min for 10 min at 4°C, the serum was collected from each group. An automatic biochemical analyzer (bs330e, Wuhan Shengshida Medical Equipment Co., Ltd., Wuhan, China) was employed to detect the content of superoxide dismutase (SOD), malondialdehyde (MDA), lactate dehydrogenase (LDH) and creatine kinase (CK). The expression of tumor necrosis factor-α (TNF-α) (PT516, Beyotime Biotechnology Co., Shanghai, China), interleukin-10 (IL-10) (QY-BM10156, Shanghai Qiao Yu Biological Technology Co., Ltd., Shanghai, China) and interleukin-6 (IL-6) (PI328, Beyotime Biotechnology Co., Shanghai, China) in serum was investigated using ELISA according to the kit operation protocol.
Detection of the area of myocardial infarction
Two hours after perfusion, the hearts of rats in each group were collected and washed with physiological saline. The large vessels, adipose tissue, atrium and right ventricle were removed, and three left ventricles were collected and placed at -20°C for 1 h. In addition, some left ventricular tissues were collected and fixed with 4% paraformaldehyde for HE staining, immunohistochemical staining and TUNEL staining. The remaining left ventricular tissues were preserved at -80°C. The left ventricles were cut along the long axis into 2 mm slices and then placed in 2 mL 1% TCC (pH 7.4) dye liquor and bathed at 37°C for 10 min. A digital microscope (Coolscope, Nikon, Tokyo, Japan) was used to take photos, and a single-blind method was used to distinguish normal areas (blue), ischemic areas (pink) and infarct areas (gray). Sigma Scan Pro area measurement software was used to calculate the percentage of infarct size in total myocardium area.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry followed by washing with water for 3 min, counterstaining with hematoxylin, dehydration, clearing and mounting. PBS was used as negative control, and a known positive slice was used as a positive control. Positive cells were those with over 25% dyeing degree with brown cell nucleus or cytoplasm. Slices were placed under an optical microscope and examined: 5 high magnification fields were randomly selected for each slice, with 100 cardiomyocytes in each view. The average value of the percentage of positive cells per slice was the positive rate.
TUNEL detection
The prepared ventricular tissue sections were embedded with conventional paraffin, and dehydrated with gradient alcohol. The TUNEL detection procedures were in strict accordance with the requirements of the TUNEL kit. Under the fluorescence microscope, 365 nm ultra violet (UV) light was used to stimulate DAPI in the same field of view, and pictures were taken when blue light was observed under microscope. Then, the 365 nm UV light was replaced with 565 nm UV light to stimulate TUNEL. When green light was observed, pictures were taken. Five non-overlapping views were randomly selected in the high power microscope in the ischemic zone (i.e., the region of apoptotic positive cells or the anterior part of the corresponding anterior wall). Apoptotic index (AI) was the percentage of apoptotic positive cells in total cellular score per unit area.
Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
Total RNA was collected from the parts of the left ventricular tissue frozen at -80°C by miRNeasy Mini Kit (217004, QIAGEN GmbH, Hilden, Germany). A 260 /A 230 and A 260 /A 280 ratios were detected on NanoDrop 2000 micro UV spectrophotometer (1011U, NanoDrop Technology, Wilmington, DE, USA) to determine the total RNA concentration and purity. The total RNA was reverse transcribed into cDNA according to TaqMan MicroRNA Assays Reverse Transcription Primer (4427975, Applied Biosystems, California, USA). Reverse transcribed cDNA was diluted to 50 ng/µL, and 2 µL was added in the 25 µL reaction amplification system each time. The reverse transcription reaction conditions were 37°C for 30 min and 85°C for 5 s. MiR-374, SP1, PI3K, Akt, GSK-3β, HO-1, p53, iNOS, and c-fos primers were designed and submitted to TaKaRa   Table 1 . Primer sequences for RT-qPCR. Notes: RTqPCR, reverse transcription quantitative polymerase chain reaction; F, Forward; R, Reverse; SP1, transcription factor SP1; PI3K, phosphatidylinositol 3 kinase; Akt, threonine protein kinase; GSK-3β, glycogen synthase kinase-3β; HO-1, heme oxygenase 1; iNOS, inducible nitric oxide synthase; c-fos, cellular oncogene fos; β-actin, cytoskeletal beta actin for synthesis (Table 1) . ABI7500 (7500, Applied Biosystems, Foster City, USA) quantitative PCR was used for RT-qPCR. The RT-qPCR condition was one cycle of initial denaturation at 95°C for 10 min, 40 cycles of denaturation at 95°C for 10 s, annealing at 60°C for 20 s and extension at 72°C for 34 s. The RT-qPCR reaction system was 20 µL: SYBR Premix Ex Taq TM II, 10 µL; PCR Forward Primer (10 µM), 0.8 µL; PCR Reverse Primer (10 µM), 0.8 µL; ROX Reference Dye, 0.4 µL; cDNA template, 2.0 µL; and distilled water, 6.0 µL. U6 was used as the internal reference for miR-374 and β-actin for SP1, PI3K, Akt, GSK-3β, HO-1, p53, iNOS and c-fos. 2 -ΔΔCt indicated the gene expression multiple proportions between experimental group and control group. The formula was as follows: ΔΔCT = ΔCt experiment group -Δct control group , and ΔCt = Ct target gene -Ct β-actin . Ct was the number of amplified cycles when the real time fluorescence intensity of the reaction reached the threshold value. Each experiment was repeated 3 times.
Western blot analysis
The left ventricular tissues were placed in a glass grinder, and 1 mL tissue lysate (BB-3209, Bestbio, Shanghai, China) was added. Then, the grinder was put into ice bath and ground to form a homogenate. The total proteins were routinely Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry extracted, and the protein concentration of each sample was determined by BCA Kit (20201ES76, Yeasen Biological Technology Co., Ltd., Shanghai, China). After protein denaturation, protein was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and then the protein on the gel was transferred to the nitrocellulose membrane. A total of 5% skimmed milk powder was added at 4°C to block the nitrocellulose membrane overnight. Then, 1:500 diluted primary rabbit anti-rat polyclonal antibodies SP1 (bs-0975R), PI3K (bs-5570R), phosphorylated (p)-Akt (bs-5194R), iNOS (bs-2072R), HO-1 (bs-2075R), p-GSK-3β (bs-5368R) and c-fos (bs-10172R) (all purchased from Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China), 1:500 diluted primary rabbit anti-rat monoclonal antibody GSK-3β (ab93926; Abcam Inc., Cambridge, MA, USA) and 1:1000 diluted primary rabbit anti-rat polyclonal antibody Akt (ABP50257, Abbkine, CA, USA), p53 (ABP50389 Abbkine, CA, USA) and β-actin (ABP57456, Abbkine, CA, USA) were added and incubated overnight. PBS was used to wash three times at room temperature, once every 5 min. Then, 1:10000 dilution of horse-radish peroxidase (HRP)-labeled IgG goat anti-rabbit secondary antibody (A21020, Abbkine, CA, USA) was added, avoiding exposure to light, and incubated at 37°C for 1 h, followed by PBS washing 3 times, once every 5 min at room temperature. The membrane reacted with ECL (ECL808-25, Biomiga, San Diego, CA, USA) for 1 min at room temperature. After absorbing the liquid, the sections were covered with the plastic wrap, and X ray was conducted (36209ES01, Qian Chen Biological Technology Co., Ltd., Shanghai, China) for observation. β-actin was used as internal reference. The ratio of the gray value between the target band and the internal reference strip was used as the relative expression of the protein.
Each experiment was repeated 3 times.
Cell extraction
The apex of the left ventricular tissues of the sham and sevoflurane + I/R groups that were frozen previously were cut into pieces of approximately 3 mm and washed with D-Hanks' liquid (HMK0011, Beijing Hua Maike Biotechnology Co., Ltd., Beijing, China). After discarding the supernatant, low sugar DMEM (SH30021, Beijing North Tongzheng Biotechnology Development Co. Ltd., Beijing, China) with 0.15% collagenase was added. The mixture was transferred to a sterile centrifuge tube and digested for 30 min using an electromagnetic stirrer (1008011909, Tianjin Tandag Trading Co. Ltd., Tianjin, China) at 37°C. Next, the mixture was centrifuged at 700 rpm/min at 4°C for 5 min to remove the supernatant. Suitable amounts of DMEM low sugar medium containing 20% fetal bovine serum were added, followed by centrifugation at 700 rpm/min at 4°C for 5 min. The deposition was added to the medium and blown into single cell suspensions. The suspensions were transferred to a disposable culture dish to be evenly distributed and washed with D-Hanks' liquid. Then, a proper volume of 0.25% trypsin (25200056, Gibco, Grand Island, USA) was added to the culture dish, which was then put into an incubator with 5% CO 2 for digestion at 37°C for 7 ~ 9 min. DMEM containing a volume fraction of 20% fetal bovine serum was added to terminate digestion. Then, the suspensions were centrifuged at 1200 rpm/min at 4°C for 5 min, with the supernatant discarded. The sections were resuspended in DMEM medium containing 20% fetal bovine serum and then inoculated into a new culture dish at 37°C. Then, the sections were put in an incubator with volume fraction of 5% CO 2 for further culture for subsequent cell experiments. Later, the culture solution was replaced every 3 days.
Dual luciferase reporter gene assay
Target gene analysis of miR-374 was performed using the biological prediction website microRNA.org. Dual luciferase reporter gene test was used to test whether SP1 was the direct target gene of miR-374. The full-length 3'UTR region of the SP1 gene was cloned and amplified (Forward: 5'-GATCTTTGCTAGGACATCCTAAATTTATATACTT-3'; Reverse: 5'-AAGTATATAAATTTAGGATGTCCTAGCAAAGATC-3'). The plasmid was extracted in accordance with the Omega plasmid small amount of extraction kit (D6943-01, Beijing Think-Far Technology Co. Ltd., Beijing, China). After restriction endonuclease Xba I and Xho I double enzyme digestion, the target fragment was connected with the luciferase reporter vector pmirGLO (E1330, Promega Corporation, Madison, USA) and transformed into Escherichia coli DH5H cells for amplification. The plasmids were named pmirGLO-SP1-3'UTR-wt and pmirGLO-SP1-3'UTR-mut. Wt and Mut with correct sequencing were co-transfected with miR-374 into HEK-293T cells (K1223, Invitrogen Life Technologies, Carlsbad, CA, USA). Then, the cells were plated at a density of 2 × 10 5 /well in 6-well plates and transfected after cell adherence. After transfection, the cells were cultured for 48 h and collected. The fluorescence intensity was measured by a fluorescence detector (Glomax20/20, Promega, Madison, Wisconsin, USA). Each experiment was repeated 3 times. 
Cell transfection and grouping
The cardiomyocytes in logarithmic growth phase were placed in 6-well plates until the cell density increased to 50% and then transfected with Lipofectamine 2000 (11668019, Thermo Fisher Scientific, San Jose, California, USA). In this procedure, 250 µl of Opti-MEM without serum (31985, Gibco, Grand Island, USA) was used to dilute 100 pmol miR-374 mimics, miR-374 inhibitors, siRNA-SP1, miR-374 inhibitors + siRNA-SP1 and negative control (the final concentration was 50 nM), followed by gently mixing and incubating at room temperature for 5 min. Next, 250 µL Opti-MEM without serum was used to dilute 5 µL Lipofectamine 2000, followed by gently mixing and incubating at room temperature for 5 min. The above two mixtures were combined, incubated at room temperature for 20 min and added to culture plates. After culture in 5% CO 2 at 37°C for 6 ~ 8 h, new medium (INV-00002, INNOVATE, Wuxi, China) was used for incubation for 24 ~ 48 h. Cell grouping was as follows: the normal group (cardiomyocytes of rats in the sham group were not transfected with any sequence), the blank group (cardiomyocytes of rats in the sevoflurane + I/R group were not transfected), the NC group (cardiomyocytes of rats in the sevoflurane + I/R group were transfected with miR-374 negative control sequences), the miR-374 mimics group (miR-374 mimics were transfected in cardiomyocytes of rats in the sevoflurane + I/R group), the miR-374 inhibitors group (miR-374 inhibitors were transfected into cardiomyocytes of rats in the sevoflurane + I/R group), the siRNA-SP1 group (siRNA-SP1 were transfected into cardiomyocytes of rats in the sevoflurane + I/R group) and the miR-374 inhibitors + siRNA-SP1 group (miR-374 inhibitors and siRNA-SP1 were co-transfected into cardiomyocytes of rats in the sevoflurane + I/R group).
MTT assay
After cell transfection for 12 h, the cells were collected, washed twice with PBS, and added with 0.25% trypsin to prepare single cell suspension. After counting, the suspensions were placed in 96-well plates (0.1 mL/well) at a density of 3 × 10 4 ~ 5 × 10 4 /well (6 wells for each group) and incubated in an incubator. The culture plates were removed separately at 0 h, 24 h, 48 h and 72 h after cell adherence. Each well had 20 μL 0.5% MTT solution added (M2128, Sigma, St. Louis, USA) and was cultured for 4 h with the supernatant removed. Each well had 100 µL dimethyl sulfoxide (DMSO) added (D5879-100ML, Sigma, St. Louis, USA), followed by gentle shaking for 10 min to fully dissolve the formazan crystals. ELISA (BS-1101, De Tie Laboratory Equipment Co., Ltd., Nanjing, China) was used to detect the absorbance value of each well at 490 nm. Each experiment was repeated 3 times. With time as the abscissa and the OD value as the ordinate, the curve of cell viability was plotted.
Flow cytometry PI single staining method: after 48 h transfection, the cells were collected, treated with 0.25% trypsin and centrifuged at 1000 r/min at 4°C for 5 min, and the supernatant was discarded. Then, the cells were washed with cold PBS 3 times and centrifuged, and the supernatant was discarded. After resuspension with PBS, the density of the cells was adjusted to approximately 1 × 10 5 /mL. Then, 2 ml 75% ethanol pre-cooled at -20°C were used to fix the cells at 4°C for 30 min. The ice-cold ethanol was discarded after centrifugation, and PBS was used for washing after the supernatant was discarded. After incubation with 100 µL RNase A at 37°C for 30 min without exposure to light, 400 µL PI dye (P4170, Sigma, St Louis, USA) was added to the cells. After mixing and avoiding exposure to light at 4°C for 30 min, flow cytometry (CytoFLEX, Beckman Coulter, CA 92821, USA) was employed to record the red fluorescence at a 488 nm stimulation wavelength to detect the cell cycle.
Annexin V/PI double parameter: after transfection for 48 h, the cells were treated by 0.25% trypsin (excluding EDTA) (PYG0107, Boster Biological Technology Co., Ltd., Wuhan, China) and collected in a tube, followed by centrifugation, and then the supernatant was discarded. Then, the cells were washed 3 times by cold PBS, after which they were centrifuged; the supernatant was discarded. According to the Annexin-V-FITC cell apoptosis detection kit (K201-100, BioVision, Milpitas, CA, USA), Annexin-V-FITC/PI dye was made of Annexin-V-FITC, PI and HEPES dye in proportion of 1: 2: 50. A total of 1 × 10 6 cells were resuspended in every 100 µL dye, after which they were evenly mixed. After incubation at room temperature for 15 min, 1 mL HEPES dye was added and then mixed. FITC and PI fluorescence were detected by excitation at 515 nm and 620 nm bandpass filters, respectively, at 488 nm, and then cell apoptosis was detected. The experiment was repeated 3 times. Flow cytometry scatter diagrams showed that the early apoptotic cells were in the lower right quadrant, necrotic and advanced apoptotic cells were in the upper right quadrant, mechanically
Results
The sevoflurane + I/R group has decreased LVEDP and increased LVDP, +dp/dtmax, -dp/ dtmax, HR and CF The indexes of cardiac function (LVEDP, LVDP, +dp/dt max , -dp/dt max , HR and CF) of rats in the sham, I/R and sevoflurane + I/R groups were detected at 30, 60, 90 and 120 min after I/R. The results showed that compared with the sham group, LVEDP in the I/R and sevoflurane + I/R groups increased significantly at 30, 60, 90 and 120 min (P < 0.05), and LVDP, +dp/ dt max , -dp/dt max , HR and CF obviously decreased (P < 0.05). Compared with the I/R group, in the sevoflurane + I/R group at 30, 60, 90 and 120 min, the LVEDP decreased observably (P < 0.05), and LVDP, +dp/dtmax, -dp/dtmax and HR increased significantly (P < 0.05). At 30 min, there was no significantly change in CF (P < 0.05), and CF increased significantly at 60, 90 and 120 min (P < 0.05) (Fig. 1) . These results suggested that the sevoflurane + I/R group has decreased LVEDP and increased LVDP, +dp/dtmax, -dp/dtmax, HR and CF.
The sevoflurane + I/R group has increased serum SOD content and decreased MDA, LDH and CK contents
Biochemical examination was conducted to measure the contents of SOD, MDA, LDH and CK. Compared with the sham group, after reperfusion for 120 min, the I/R and sevoflurane + I/R groups had remarkably decreased content of serum SOD (P < 0.05) and evidently increased contents of MDA, LDH and CK (P < 0.05). Compared with the I/R group, in the sevoflurane + I/R group the content of serum SOD was observably increased (P < 0.05), and the contents of MDA, LDH and CK decreased significantly (P < 0.05) ( Table 2 ). The content of LDH in serum of rats in the I/R and sevoflurane + I/R groups increased significantly, Fig. 1 . Results of cardiac function tests after I/R at 30, 60, 90, and 120 min. Notes: A, LVEDP; B, LVDP; C, +dp/dt max ; D, -dp/dt max ; E, HR; F, CF; *, P<0.05 compared with the sham group; #, P<0.05 compared with the I/R group; sham group (n =15); I/R group (n = 15); Sevoflurane + I/R group (n =15); LVEDP, left ventricular end diastolic pressure; LVDP, left ventricular developed pressure; +dp/dt max , left ventricular pressure rising maximum rate; -dp/dt max , left ventricular pressure dropping maximum rate; HR, heart rate; CF, coronary flow; I/R, ischemia and reperfusion. 
suggesting the injury to myocardial tissue and successful modeling.
Rats in the sevoflurane + I/R group have reduced contents of TNF-α and IL-6 and increased content of IL-10
ELISA was performed to determine the levels of TNF-α, IL-6 and IL-10 in serum of rats in each group, and results demonstrated that after reperfusion 120 min, the levels of TNF-α, IL-6 and IL-10 in serum of rats in the I/R and sevoflurane + I/R groups were raised observably compared with the sham group (P < 0.05). Compared with the I/R group, contents of TNF-α and IL-6 in serum of rats in the sevoflurane + I/R group were reduced evidently (P < 0.05), and content of IL-10 increased significantly (P < 0.05) ( Table 3 ). The abovementioned results demonstrated that rats in the sevoflurane + I/R group have reduced contents of TNF-α and IL-6 and increased content of IL-10.
The percentage of infarct size after reperfusion for 120 min in the sevoflurane + I/R group is decreased markedly
Next, the left ventricular infarct size in each group was observed. The percentage of infarct size in the I/R and sevoflurane + I/R groups increased significantly compared with the sham group after reperfusion for 120 min (P < 0.05). Compared with the I/R group, the percentage of infarct size after reperfusion for 120 min in the sevoflurane + I/R group decreased markedly (P < 0.05) (Fig. 2) .
The myocardial tissue damage and leukocyte infiltration is decreased in the sevoflurane + I/R group
Histopathological examination for left ventricular myocardial tissues of rats in each group was further observed. In the sham group, the structure of myocardial fiber of the Table 2 . Biochemical examination of the SOD, MDA, LDH and CK contents in serum of rats in each group after reperfusion for 120 min. Notes: SOD, superoxide dismutase; MDA, malondialdehyde; LDH, lactate dehydrogenase; CK, creatine kinase; *, P < 0.05 compared with the sham group; #, P < 0.05 compared with the I/R group; sham group (n =15); I/R group (n = 15); Sevoflurane + I/R group (n =15); I/R, ischemia and reperfusion Table 3 . The levels of TNF-α, IL-6 and IL-10 in serum of rats in each group. Note: TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; IL-10, interleukin-10; *, compared with the sham group, P < 0.05; #, compared with the I/R group, P < 0.05; sham group (n =15); I/R group (n = 15); Sevoflurane + I/R group (n =15); I/R, ischemia and reperfusion
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry left ventricular myocardial tissue was normal, and there was no congestion or edema in mesenchyme. In the I/R and sevoflurane + I/R groups, there was edema in the interstitial tissue of myocardial fiber, the connective tissue was loose, and a few leukocytes were infiltrated around the vessels. The myocardial tissue damage and leukocyte infiltration decreased in the sevoflurane + I/R group (Fig. 3) .
Positive rate of SP1 protein in myocardial tissue of the sevoflurane + I/R group is evidently lowered
The SP1 protein positive rate in myocardium of rats in each group was determined by immunohistochemical staining. Normal cells were stained blue in the nuclei. SP1 protein was localized in the nucleus or cytoplasm and was brown when positively expressed. In the sham group, the positive rate of SP1 protein was (13.31 ± 1.52)% (P < 0.05); a small amount of brown granules could be seen in the cardiomyocytes. In the I/R group, the positive rate of SP1 protein was (60.82 ± 3.23)% (P < 0.05). In the sevoflurane + I/R group, the positive rate of SP1 protein was (22.32 ± 1.56)% (P < 0.05), and more scattered brown granules could be seen. Compared with the sham group, in the I/R and sevoflurane + I/R groups, the positive rate of SP1 protein in myocardial tissue was significantly increased (P < 0.05). Compared with the I/R group, the positive rate of SP1 protein in myocardial tissue of sevoflurane + I/R group was evidently lowered (P < 0.05) (Fig. 4) .
Apoptosis index is evidently decreased in the sevoflurane + I/R group
After DAPI staining, fluorescence microscopy showed that all cell nuclei were blue, and green fluorescence of TUNEL staining represented positive staining. Compared with the sham group (5.03 ± 0.52)%, the apoptosis indexes of myocardial tissues of rats in the I/R (28.63 ± 2.91)% and sevoflurane + I/R (16.11 ± 1.75)% groups increased sharply (P < 0.05). Compared with the I/R group, the apoptosis index decreased evidently in the sevoflurane + I/R group (P < 0.05) (Fig. 5) .
The sevoflurane + I/R group has increased expression of miR-374, PI3K, HO-1, Akt, and GSK-3β and protein phosphorylation levels of p-Akt and p-GSK-3β but decreased expression of SP1, p53, iNOS and c-fos
As revealed RT-qPCR and Western blot analysis, compared with the sham group, after reperfusion in the I/R and sevoflurane + I/R groups, the relative expression of miR-374 in 
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry myocardium of rats was significantly lowered (P < 0.05). The relative mRNA and protein expression of SP1, PI3K, HO-1, p53, iNOS and c-fos, the mRNA expression of Akt and GSK-3β and the protein phosphorylation levels of p-Akt and p-GSK-3β significantly increased (P < 0.05), while there was no significant change in the expression of Akt and GSK-3β proteins (P > 0.05). Compared with the I/R group, in the sevoflurane + I/R group, the relative expression of miR-374 in myocardium of rats was evidently increased (P < 0.05), the mRNA and protein expression of SP1, p53, iNOS and c-fos was markedly reduced (P < 0.05) and the mRNA and protein expression of PI3K and HO-1, the mRNA expression of Akt and GSK-3β and protein phosphorylation levels of p-Akt and p-GSK-3β were remarkably increased (P < 0.05), while there was no significant change in the expression of Akt and GSK-3β proteins (P > 0.05) (Fig.  6) . In view of this, the sevoflurane + I/R group has increased expression of miR-374, PI3K and HO-1, Akt, and GSK-3β and protein phosphorylation levels of p-Akt and p-GSK-3β, but decreased expression of SP1, p53, iNOS and c-fos.
SP1is a target gene of miR-374
MicroRNA.org showed that miR-374 was able to target SP1, proving that SP1 was a direct target gene of miR-374. A dual luciferase reporter gene assay was used to confirm that SP1 was a target gene of miR-374. Compared with the NC group, the luciferase activity of the SP1 wild-type 3'-UTR was significantly inhibited by miR-374 (P < 0.05), while the luciferase activity of the mutant 3'-UTR was not inhibited (Fig. 7) . These results indicated that miR-374 could specifically bind SP1-3'-UTR and downregulate the expression of the SP1 gene at the post-transcriptional level. Cell
miR-374 inhibits the expression of SP1 through activating the PI3K/Akt pathway
As suggested by the results of RT-qPCR and Western blot analysis, compared with the normal group, in the blank, NC, miR-374 mimics, miR-374 inhibitors, siRNA-SP1 and miR-374 inhibitors + siRNA-SP1 groups, the relative expression of miR-374 in cardiomyocytes significantly decreased (P < 0.05). The mRNA and protein expression of SP1, PI3K, HO-1, p53, iNOS and c-fos, the mRNA expression of Akt and GSK-3β and the protein phosphorylation level of p-Akt and p-GSK-3β evidently increased (P < 0.05), while there was no significant change in the expression of Akt and GSK-3β (P > 0.05). Compared with the NC group, in the blank group, the relative expression of miR-374 and the mRNA and protein expression of related genes was not significantly different (P > 0.05). Compared with the blank and NC groups, the relative expression of miR-374 in the miR-374 mimics group were notably increased (P < 0.05), and there was no significant difference in the relative expression of miR-374 in cardiomyocytes of the siRNA-SP1 group (P > 0.05). In the miR-374 mimics and siRNA-SP1 groups, the mRNA and protein expression of SP1, p53, iNOS and c-fos in cardiomyocytes decreased markedly (P < 0.05), while the mRNA and protein expression of PI3K and HO-1, mRNA expression of Akt and GSK-3β and protein phosphorylation levels of p-Akt and p-GSK-3β evidently increased (P < 0.05), with no obvious change of protein expression in Akt and GSK-3β (P > 0.05). In the miR-374 inhibitors group, the relative expression of miR-374 in cardiomyocytes decreased evidently (P < 0.05), the mRNA and protein expression of SP1, p53, iNOS and c-fos increased significantly (P < 0.05), and the mRNA and protein expression of PI3K and HO-1, mRNA expression of Akt and GSK-3β and protein phosphorylation levels of p-Akt and p-GSK-3β were evidently lowered (P < 0.05), with no evident change in the protein expression of Akt and GSK-3β (P > 0.05). In the miR-374 inhibitors + siRNA-SP1 group, the relative expression of miR-374 in cardiomyocytes decreased significantly (P < 0.05), and the mRNA and protein expression of other related genes and the levels of protein phosphorylation of p-Akt and p-GSK-3β did not change significantly (P > 0.05) (Fig. 8) . These results demonstrated that miR-374 inhibits expression of SP1 through activating the PI3K/ Akt pathway.
Upregulation of miR-374 and downregulation of SP1 promotes proliferation of cardiomyocytes after transfection
The MTT assay was used to detect cell proliferation. The proliferation of cardiomyocytes in each group accelerated at 24 h, 48 h and 72 h. The proliferation ability of cardiomyocytes in each group at 0 h was not significantly different but became significantly different at 24 ~ 72 h. Compared with the normal group, in the blank, NC, miR-374 mimics, miR-374 inhibitors, siRNA-SP1 and miR-374 inhibitors + siRNA-SP1 groups, the proliferation abilities of cardiomyocytes decreased (P < 0.05). There was no significant difference in cell proliferation ability between the blank group and the NC group and between the miR-374 mimics group and the siRNA-SP1 group (P > 0.05). Compared with the blank and NC groups, 
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Cellular Physiology and Biochemistry the proliferation rate of cardiomyocytes increased significantly in the miR-374 mimics and siRNA-SP1 groups (P < 0.05) and notably decreased in the miR-374 inhibitors group (P < 0.05), with no obvious change in the miR-374 inhibitors + siRNA-SP1 group (P > 0.05) (Fig. 9) . These results suggested that upregulation of miR-374 and downregulation of SP1 promotes proliferation of cardiomyocytes after transfection.
Upregulation of miR-374 and downregulation of SP1 arrests more cells at G1 phase and inhibits apoptosis of cells after transfection
PI single staining was used to detect the cell cycle distribution. In comparison with the normal group, in the blank, NC, miR-374 mimics, miR-374 inhibitors, siRNA-SP1 and miR-374 inhibitors + siRNA-SP1 groups, the percentage of G1 phase cells increased evidently (P < 0.05), and the percentage of S phase cells decreased significantly (P < 0.05). There was no significant difference in cell cycle distribution between the blank group and the NC group and between the miR-374 mimics group and the siRNA-SP1 group (P > 0.05). Compared with the blank and NC groups, in the miR-374 mimics and siRNA-SP1 groups, the percentage of G1 phase cells decreased significantly (P < 0.05) and the percentage of S phase cells increased remarkably (P < 0.05). In the miR-374 inhibitors group, the percentage of G1 phase cells increased evidently (P < 0.05) and the percentage of S phase cells decreased significantly (P < 0.05). There was no significant difference in cell cycle distribution in the miR-374 inhibitors + siRNA-SP1 group (P > 0.05). There was no significant difference in G2 phase ratio between any two groups (P > 0.05) (Fig. 10) . It can be concluded that upregulation of miR-374 and downregulation of SP1 arrests more cells at G1 phase. Annexin V/PI double staining was used to detect cell apoptosis. Compared with the normal group, in the blank, NC, miR-374 mimics, miR-374 inhibitors, siRNA-SP1 and miR-374 inhibitors + siRNA-SP1 groups, the apoptosis rate of cardiomyocytes increased markedly (P < 0.05). Between the blank group and the NC group and between the miR-374 mimics group and the siRNA-SP1 group, there was no significant difference in myocardial apoptosis rate (P > 0.05). Compared with the blank and NC groups, in the miR-374 mimics and siRNA-SP1 groups, the apoptosis rate of cardiomyocytes decreased significantly (P < 0.05), and the apoptosis rate of cardiomyocytes in the miR-374 inhibitors group increased markedly (P < 0.05). There was no significant difference in cell apoptosis rate in the miR-374 inhibitors + siRNA-SP1 group (P > 0.05) (Fig. 11) . These findings suggest that upregulation of miR-374 and downregulation of SP1 inhibits apoptosis of cells after transfection.
Discussion
As one of the leading causes of death, the deleterious effects of myocardial I/R have been studied over the past 40 years [17] . Therefore, this study was supposed to explore the effects of miR-374 in myocardial I/R rat models that were pretreated with sevoflurane by targeting transcription factor SP1 through the PI3K/Akt pathway. The results showed that miR-374 could be a therapeutic target for myocardial I/R by targeting transcription factor SP1 through the PI3K/Akt pathway in rats after treatment with sevoflurane. 
Figure 10
The cycle distribution of cardiomyocytes in each group after transfection Notes: A, Flow cytometry; B, comparison of cell cycle distribution; *, P < 0.05 compared to the normal group; #, P < 0.05 compared to the blank and NC groups; the experiment was repeated three times; I/R, ischemia and reperfusion. Fig. 11 . Apoptosis rate of cardiomyocytes in each group after transfection. Notes: A, apoptotic scatter plot; B, comparisons of apoptosis rates in each group; *, P<0.05 compared to the normal group; #, P<0.05 compared to the blank and NC groups; the experiment was repeated three times; I/R, ischemia and reperfusion.
Figure 11
Apoptosis rate of cardiomyocytes in each group after transfection Notes: A, apoptotic scatter plot; B, comparisons of apoptosis rates in each group; *, P < 0.05 compared to the normal group; #, P < 0.05 compared to the blank and NC groups; the experiment was repeated three times; I/R, ischemia and reperfusion. Experimental results of a dual luciferase reporter gene assay showed that compared with the NC group, the luciferase activity of the SP1 wild-type 3'-UTR was significantly inhibited by miR-374 (P > 0.05), while the luciferase activity of mutant 3'-UTR was not inhibited (P < 0.05). These results indicated that miR-374 could specifically bind SP1-3'-UTR and downregulate the expression of the SP1 gene at the post-transcriptional level. That is to say, SP1 is a direct target gene of miR-374. A recent study has demonstrated that by interacting with p16
INK4a through the fourth ankyrin repeat, SP1 could combine with the promoters of miR-141 and miR-146b-5p and their transcriptional activation [18] . Recently, a study showed that within the Bcl-2 and SP1 mRNA 3'UTRs, miR-429 could combine with putative binding sites to lower their expression; through targeting Bcl-2 and SP1, up-regulation of miR-429 could depress invasion and advance apoptosis in esophageal carcinoma cells, indicating that Bcl-2 and SP1 could be major targets of miR-429 [19] .
Compared with the normal group, in the blank, NC, miR-374 mimics, miR-374 inhibitors, siRNA-SP1 and miR-374 inhibitors + siRNA-SP1 groups, the relative expression of miR-374 in cardiomyocytes decreased significantly (P < 0.05). SP1, which is a major transcription factor in cellular processes, could recruit and interact with some proteins, remodel chromatin and regulate gene expression [20] . Consistent with the results in this study, Yang et al. found that SP1 increased miR-182 expression, and knockdown of miR-182 inhibited lung cancer cell growth but improved the invasive and migratory abilities of cells by enhancing N-cadherin expression [21] .
Compared with the normal group, in the blank, NC, miR-374 mimics, miR-374 inhibitors, siRNA-SP1 and miR-374 inhibitors + siRNA-SP1 groups, the mRNA and protein expression of SP1, PI3K, HO-1, p53, iNOS and c-fos, the mRNA expression of Akt and GSK-3β, and the protein phosphorylation levels of p-Akt and p-GSK-3β were evidently increased (P < 0.05). The results indicated that miR-374 activates the PI3K/Akt pathway. In a recent study, through directly binding the 3' untranslated regions of the tumor-suppressor genes PTEN and CDKN1A, miR-93 inhibited their expression and activated the c-Met/PI3K/Akt pathway by regulating c-Met protein expression [22] . Furthermore, Chen et al. found that after overexpression of miR-374a, the PI3K/Akt signaling pathway and its downstream cell cycle factors, including c-myc, CDK4, CCND1 and EMT-related genes such as ZEB1, Snail, Vimentin and N-cadherin, were downregulated [12] .
MiR-374 may alleviate myocardial I/R damage in rat models pretreated with sevoflurane by targeting transcription factor SP1 through activating the PI3K/Akt pathway. With mammalian target of rapamycin (mTOR), one of its downstream targets, the PI3K/Akt pathway plays a protective role in myocardial I/R injury [23] . As small (22 nt), noncoding, single-stranded RNA molecules that can downregulate gene expressions, miRNAs are considered to regulate a great number of heart diseases, such as heart failure, hypertrophy, remodeling and arrhythmia, and to significantly alleviate I/R injury through altering key signaling elements [11] . In a study conducted by Li Song e t al., up-regulation of the expression of miR-320 in the rat model might exacerbate the risk of left ventricular remodeling after myocardial I/R injury, while decreased expression of miR-320 might reduce the risk and even promoted cardiac function [24] . We found that compared with the I/R group, in the SR group, the content of SOD and IL-10 increased, while the content of MDA, LDH, CK, TNF-α and IL-6 decreased, as did the percentage of infarct area and the apoptosis index. Increased SOD levels and decreased levels of LDH, CK, MDA, TNF-α, and IL-6 and infarct size induced by I/R indicated alleviation of myocardial I/R injury [25] . Consistent with the results of this study, Tian et al. proved that compared with the I/R group, the levels of CK, LDH, MDA, IL-6, and TNF-α, as well as the infarct size and cell apoptosis, were decreased in the hearts of the rats in the Echinatin-treated group, while the SOD activity increased, suggesting improvement of I/R injury [26] . Additionally, it was observed that compared with the blank and NC groups, in the miR-374 mimics and siRNA-SP1 groups, the cell proliferation ability was enhanced, while the cell apoptosis rate decreased. There were no obvious changes in cell proliferation, cycle distribution and apoptosis rate in the miR-374 inhibitors + siRNA-SP1 group. Enhanced cardiac c-kit+ cell survival and proliferation and decreased apoptotic activity were positive indicators of myocardial infarction [27] . Chen et al. witnessed an evident increase in cell proliferation and TNF-induced apoptosis in neonatal rat cardiac myocytes, suggesting a prevention of M6P/IGF2R against cell death or promotion to mitogenesis for certain heart diseases [28] .
Conclusion
Our study provided evidence that miR-374 could alleviate myocardial I/R damage by targeting SP1 through activating the PI3K/Akt pathway. Nevertheless, we suggested that more prospective studies with larger sample size should be conducted to provide more precise estimates to confirm the effects of miR-374 on myocardial I/R, to get closer to the goal of developing new genetic therapeutic strategies for the treatment of ischemic heart disease.
